ABPI

News

The ABPI is worried about investment in medicines and moves that could limit patient and doctor treatment choice in the NHS 10-year plan.

News

UK pharma firms have reacted angrily to the news that the government has doubled the statutory scheme rebate on the sales of newer drugs to the NHS.

Market Access

With the ABPI wanting to change the scheme just over a year into its five-year term, it seems that they have buyer’s remorse.

News

UK pharma leaders have renewed calls for a rethink by the government on levies imposed on medicine sales, saying investment is already being hit.

Market Access

Leela Barham provides a perspective on the ABPI blog that covers understanding NHS medicines spending in England.

News

Novo Nordisk has reached the end of its two-year suspension from the ABPI for breaches of its code of practice after making "sustained improvements."